Alpha Tau Medical Ltd. (DRTS) vs LB Pharmaceuticals Inc (LBRX)

Alpha Tau Medical Ltd. and LB Pharmaceuticals Inc are both Biotechnology companies. Alpha Tau Medical Ltd. and LB Pharmaceuticals Inc are of similar size ($1.2B and $1.2B). Across the 10 metrics below, Alpha Tau Medical Ltd. leads on 6 and LB Pharmaceuticals Inc on 4.

Valuation

Metric DRTS LBRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 25.03 3.33 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (4.56%) (9.36%) (33.15%)
Free cash flow yield (3.55%) (7.48%) (25.50%)

Profitability

Metric DRTS LBRX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (72.07%) (56.36%)
Return on assets 0.00% (47.38%) (48.04%)
Return on invested capital 0.00% (1,304.79%) 0.00%

Growth

Metric DRTS LBRX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (17.78%) 98.22% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DRTS LBRX Biotechnology median
Debt to equity 0.15 0.00 0.00
Current ratio 11.09 15.08 4.72
Net debt to EBITDA 1.63 9.90 0.96

Dividend

Metric DRTS LBRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DRTS LBRX Biotechnology median
Market cap 1.22b 1.18b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack